These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 26333304)

  • 1. Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.
    Zhang N; Chen X
    Biotechnol Appl Biochem; 2016 Nov; 63(6):841-851. PubMed ID: 26333304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-GlcNAcylation enhances the invasion of thyroid anaplastic cancer cells partially by PI3K/Akt1 pathway.
    Zhang P; Wang C; Ma T; You S
    Onco Targets Ther; 2015; 8():3305-13. PubMed ID: 26635480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
    de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
    J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
    Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
    Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy.
    Mi W; Gu Y; Han C; Liu H; Fan Q; Zhang X; Cong Q; Yu W
    Biochim Biophys Acta; 2011 Apr; 1812(4):514-9. PubMed ID: 21255644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells.
    Goldberg H; Whiteside C; Fantus IG
    Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E713-26. PubMed ID: 21712532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated O-GlcNAcylation Promotes Malignant Phenotypes of Hypopharyngeal Squamous Cell Carcinoma by Stabilizing Nrf2 through Regulation of the PI3K/Akt Pathway.
    Dai W; Jin X; Jiang B; Chen W; Ji Z; Xu X; Tang M; Dai K; Han L
    Anticancer Agents Med Chem; 2020; 20(16):1933-1942. PubMed ID: 32538734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of β-N-acetyl-D-glucosaminidase increases Akt1 activity in thyroid anaplastic cancer cells.
    Krześlak A; Jóźwiak P; Lipińska A
    Oncol Rep; 2011 Sep; 26(3):743-9. PubMed ID: 21637923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.
    Shukla S; Maclennan GT; Hartman DJ; Fu P; Resnick MI; Gupta S
    Int J Cancer; 2007 Oct; 121(7):1424-32. PubMed ID: 17551921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated O-GlcNAcylation stabilizes FOXM1 by its reduced degradation through GSK-3β inactivation in a human gastric carcinoma cell line, MKN45 cells.
    Inoue Y; Moriwaki K; Ueda Y; Takeuchi T; Higuchi K; Asahi M
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1681-1687. PubMed ID: 29196265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-GlcNAcylation enhances anaplastic thyroid carcinoma malignancy.
    Cheng YU; Li H; Li J; Li J; Gao Y; Liu B
    Oncol Lett; 2016 Jul; 12(1):572-578. PubMed ID: 27347182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-GlcNAcylation promotes migration and invasion in human ovarian cancer cells via the RhoA/ROCK/MLC pathway.
    Niu Y; Xia Y; Wang J; Shi X
    Mol Med Rep; 2017 Apr; 15(4):2083-2089. PubMed ID: 28259907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT.
    Sun C; Tao Y; Gao Y; Xia Y; Liu Y; Wang G; Gu Y
    Biomed Pharmacother; 2018 Feb; 98():416-423. PubMed ID: 29278851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.
    Kang MH; Kim JS; Seo JE; Oh SC; Yoo YA
    Exp Cell Res; 2010 Jan; 316(1):24-37. PubMed ID: 19835871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
    Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
    Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-GlcNAc modulation at Akt1 Ser473 correlates with apoptosis of murine pancreatic beta cells.
    Kang ES; Han D; Park J; Kwak TK; Oh MA; Lee SA; Choi S; Park ZY; Kim Y; Lee JW
    Exp Cell Res; 2008 Jul; 314(11-12):2238-48. PubMed ID: 18570920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased O-GlcNAcylation promotes IGF-1 receptor/PhosphatidyI Inositol-3 kinase/Akt pathway in cervical cancer cells.
    Jiménez-Castillo V; Illescas-Barbosa D; Zenteno E; Ávila-Curiel BX; Castañeda-Patlán MC; Robles-Flores M; De Oca DM; Pérez-Campos E; Torres-Rivera A; Bouaboud A; Pagesy P; Solórzano-Mata CJ; Issad T
    Sci Rep; 2022 Mar; 12(1):4464. PubMed ID: 35296731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1.
    Caldwell SA; Jackson SR; Shahriari KS; Lynch TP; Sethi G; Walker S; Vosseller K; Reginato MJ
    Oncogene; 2010 May; 29(19):2831-42. PubMed ID: 20190804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OGT regulated O-GlcNacylation promotes migration and invasion by activating IL-6/STAT3 signaling in NSCLC cells.
    Ge X; Peng X; Li M; Ji F; Chen J; Zhang D
    Pathol Res Pract; 2021 Sep; 225():153580. PubMed ID: 34391182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing β-linked N-acetylglucosamine transferase induces apoptosis in human gastric cancer cells through PUMA and caspase-3 pathways.
    Wen T; Hou K; Li Z; Li L; Yu H; Liu Y; Li Y; Yin Z
    Oncol Rep; 2015 Dec; 34(6):3140-6. PubMed ID: 26397041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.